Science
Extensive study identifies over a dozen existing drugs as potential COVID-19 therapies – EurekAlert
Mining the world’s most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral…
IMAGE: A researcher at Calibr, the drug discovery division of Scripps Research, working in the high-throughput screening facility used to identify potential COVID-19 therapies.
view more
Credit: Scripps Research
June 3, 2021 – LA JOLLA, CA–Mining the world’s most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral activity against the coronavirus that’s driving the ongoing global pandemic.
Among those…
-
Business12 hours agoWarning! These ASX 200 shares were just downgraded
-
Business10 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
General9 hours agoFatal house fire at Lake Illawarra under police investigation
-
Business12 hours agoAfter falling more than 20% on its FY25 result, are Inghams shares a buy the dip opportunity?